1. Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

   • Moshe C. Ornstein
   • Laura S. Wood

   Commentary Open access 26 May 2023 Pages: 3599 - 3609

   

2. A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma

   • Philipp Ivanyi
   • Jonas Paul Wiegmann
   • Viktor Grünwald

   Commentary Open access 12 July 2023 Pages: 3610 - 3619

3. First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely

   • Philipp Ivanyi
   • Jonas Paul Wiegmann
   • Viktor Grünwald

   Commentary Open access 12 July 2023 Pages: 3620 - 3625

4. Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations

   • Nathan Z. Pearl
   • Caroline P. Babin
   • Alan D. Kaye

   Review 27 June 2023 Pages: 3626 - 3638

   

5. Burden and Treatment of Achondroplasia: A Systematic Literature Review

   • Molly C. Murton
   • Emma L. A. Drane
   • Thomas J. Butt

   Review Open access 29 June 2023 Pages: 3639 - 3680

   

6. Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review

   • Alvaro Sanabria
   • María Paula Olivera
   • Alfio Ferlito

   Review Open access 12 July 2023 Pages: 3681 - 3696

   

7. Desmoid Tumors: A Comprehensive Review

   • Meryem Bektas
   • Timothy Bell
   • Ana B. Oton

   Review Open access 12 July 2023 Pages: 3697 - 3722

   

8. Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States

   • Yizhou Ye
   • Xiaomeng Yue
   • Seoyoung C. Kim

   Original Research Open access 20 June 2023 Pages: 3723 - 3738

   

9. Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients

   • Alan Faraj
   • Natacha Le Moan
   • Ulrika S. H. Simonsson

   Original Research Open access 21 June 2023 Pages: 3739 - 3750

   

10. Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective

    • Gérard de Pouvourville
    • Patrick Rossignol
    • Juan Jose Garcia Sanchez

    Original Research Open access 21 June 2023 Pages: 3751 - 3769

    

11. Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries

    • Eva Funding
    • Gillian Lowe
    • Carly Rich

    Original Research Open access 23 June 2023 Pages: 3770 - 3783

    

12. Sugammadex Reduced the Incidence of Postoperative Pulmonary Complications in Susceptible Patients Identified by ARISCAT Risk Index: Systematic Review and Meta-analysis

    • Yun-Xiao Bai
    • Jing-Jing Han
    • Qing-Ping Wu

    Original Research 23 June 2023 Pages: 3784 - 3803

    

13. Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study

    • Min Zheng
    • Xiang Chen
    • Jie Zheng

    Original Research 25 June 2023 Pages: 3804 - 3816

    

14. Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China

    • Xinhua Zhang
    • Peng Zhang
    • Jian Li

    Original Research Open access 25 June 2023 Pages: 3817 - 3829

    

15. Analyses of Dupilumab-Related Ocular Adverse Drug Reactions Using the WHO’s VigiBase

    • Eri Hirai
    • Tomoko Haruki
    • Dai Miyazaki

    Original Research 26 June 2023 Pages: 3830 - 3856

    

16. Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States

    • Jesse A. Sussell
    • David J. Press
    • Anita Fung

    Original Research Open access 26 June 2023 Pages: 3857 - 3874

    

17. Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy

    • Ilaria Gioia Marcon
    • Diletta Valsecchi
    • Luca Degli Esposti

    Original Research Open access 27 June 2023 Pages: 3875 - 3895

    

18. Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn’s Disease

    • Marla Dubinsky
    • Christopher Ma
    • Tom O’Connell

    Original Research Open access 27 June 2023 Pages: 3896 - 3911

    

19. The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer

    • Maoli Wang
    • Mingdi Zhang
    • Hongliang Chen

    Original Research 29 June 2023 Pages: 3912 - 3925

    

20. The Relationship Between Signature Time and Functional Health Literacy: Results from a Prospective Study of an Urban Low-Income Population Receiving Long-Term Anticoagulation

    • Ali Alobaidi
    • Connie H. Yan
    • Edith A. Nutescu

    Original Research Open access 30 June 2023 Pages: 3926 - 3936

    

21. Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies

    • Jürgen Behr
    • Steven D. Nathan
    • Lisa Lancaster

    Original Research Open access 30 June 2023 Pages: 3937 - 3955

    

22. Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients

    • Pierre Pommerolle
    • Pierre Laurent
    • Ophélie Fourdinier

    Original Research 01 July 2023 Pages: 3956 - 3970

    

23. Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study

    • Manfei Si
    • Xinyu Qi
    • Jie Qiao

    Original Research Open access 03 July 2023 Pages: 3971 - 3985

    

24. Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US

    • Michael Hull
    • Vamshi Ruthwik Anupindi
    • Jonathan Bouchard

    Original Research Open access 07 July 2023 Pages: 3986 - 4003

    

25. Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis

    • Yu-Lu Sun
    • Yi-Xin Zhao
    • Yong-Zhong Yao

    Original Research 09 July 2023 Pages: 4004 - 4023

    

26. Application of Autologous Hair Transplantation Technique in Children with Cicatricial Alopecia

    • Jiping Wang
    • Jing Liu
    • Yanni Wang

    Original Research Open access 11 July 2023 Pages: 4024 - 4031

    

27. Neuroendocrine Component in Extrahepatic Cholangiocarcinoma is Associated with Better Survival: Data from the SEER Study

    • Tian-Run Lv
    • Fei Liu
    • Fu-Yu Li

    Original Research 11 July 2023 Pages: 4032 - 4041

    

28. Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management

    • Peter Daley-Yates
    • Dave Singh
    • Maximilian Plank

    Original Research Open access 12 July 2023 Pages: 4042 - 4059

    

29. Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale

    • Irene Santi
    • Andrew J. Lloyd
    • Matthijs M. Versteegh

    Original Research Open access 13 July 2023 Pages: 4060 - 4073

    

30. Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study

    • Masaru Inatani
    • Yusuke Orii
    • Masaki Tanito

    Original Research Open access 15 July 2023 Pages: 4074 - 4092

    

31. Characterizing Opioid Use Disorder Encounters in the Midwest Region, USA

    • Yifei Liu
    • Suman Sahil
    • Holly N. Hagle

    Brief Report 28 June 2023 Pages: 4093 - 4100

32. B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection

    • Jennifer Cremer
    • Robert Elston
    • Dickens Theodore

    Study Protocol Open access 01 July 2023 Pages: 4101 - 4110

    

33. Letter to the Editor Regarding “Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single Agent Pembrolizumab for High-Risk Early-Stage Triple Negative Breast Cancer in the United States”

    • Steven Sorscher

    Letter 11 July 2023 Pages: 4111 - 4113

34. Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

    • Thomas Bieber
    • Eugen Feist
    • Peter C. Taylor

    Correction Open access 22 June 2023 Pages: 4114 - 4115

35. Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

    • Moshe C. Ornstein
    • Laura S. Wood

    Correction Open access 13 July 2023 Pages: 4116 - 4116